Press Releases

GB Sciences Files Provisional Patent Application for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS), the Leading Cause of Hospitalization and Deaths, Utilizing Its Cannabinoid Containing Complex Mixtures (CCCM(TM))

GB Sciences Announces Issuance of US Patent for Its Proprietary Pain Formulations for the 560 Billion Dollar Chronic Pain Treatment Market

GB Sciences Announces Issuance of US Patent for Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease

GB Sciences Completes and Achieves Statistical Significance in Preclinical Study of Its Proprietary Parkinson’s Disease Cannabinoid Formulations and Begins Mechanism of Action Study With the National Research Council of Canada

GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson’s Disease and Neuropathic Pain

GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP developed under GB Sciences Louisiana’s Master Research and Development Agreement

GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors

GB Sciences’ Chief Science Officer Featured on the Cover of the Marijuana Business Magazine

GB SCIENCES SELLS ITS LOUISIANA MEDICAL MARIJUANA BUSINESS AT A $32 MILLION TOTAL VALUATION

U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers

GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists

History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History

GB SCIENCES FILES NOVEL PATENT APPLICATION FOR CHRONIC PAIN TREATMENTS BASED ON PROPRIETARY CANNABIS-DERIVED FORMULATIONS

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility

GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center

Today: GB Sciences’ Use of Controlled Cultivation, Product Formulations and Research Was Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times

GB Sciences Study Shows Nevada’s Cannabis Strain Names Have No Correlation to Active Ingredients

GB Sciences in Benzinga Piece

GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc.

GB Sciences Supports the Position of LSU AgCenter: Allegations Made by Commissioner Are Untrue

Statement From LSU AgCenter on False Allegations Made by LDAF Commissioner

Beyond THC: A Deeper Look at the Endocannabinoid System

GB Sciences Completes Harvest of First Cannabis Crop in Partnership with The Louisiana State University Agricultural Research Center

GB Sciences Declares a “Research Revolution” at its “2018 Innovation in Medical Cannabis Therapies” Symposium

GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated

GB Sciences Expands into the Oklahoma Medical Cannabis Market

GB SCIENCES SPONSORS “2018 INNOVATION IN MEDICAL CANNABIS THERAPIES” SYMPOSIUM

We All Should Be Asking Lots More Questions As CBD’s Potential Is Revealed

Could CBD affect Alzheimer’s Disease, Bust Up Brain Plaque? — Boosting PPAR-Gamma

The Magic of CBD and Orphan Receptors— Saving Bones and Slowing Cancer

Video: Dr. Small-Howard Leads “State of Cannabis” Panel

GB Sciences Harvests the First Hemp Crop in Colorado

CBD & Anxiety Relief without the High — Changing the Shape of Receptors

GB Sciences Team to Present at Digital Hollywood Forum

CBD & Pain Relief Via a Receptor Called Vanilloid

CBD at Work: What the Heck are Receptors?

Dr. Andrea Small-Howard Presents Research Results at UCLA’s CannMed

How CBD Works as a Multi-Tasker

DEA Rescheduling Benefits GB Sciences

Catalent to Provide Parkinson’s Therapy Delivery Systems

GB Sciences Granted a Recreational Production License

November “Innovation in Medical Cannabis Therapies Symposium

GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery

Dr. Small-Howard to head panel at “State of Cannabis” Conference

A ROLL OUT FOR LOUISIANA’S MEDICAL MARIJUANA PROGRAM

Shopping at CBD dispensaries – Part One

Nine Pharmacies to Serve Louisiana

Louisiana Partnership Yields Cultivation of First Cannabis Crop

First Quarter Revenue

Louisiana’s First Medical Pot Crop Delayed by Regs

Peer-Reviewed Article for American Heart Association

Part II: Pain, Opioids, and Cannabis

GB Sciences Strengthens Compliance Program

GB Sciences Enters Hemp Market

In a Bad Way: Pain, Opioids, and Cannabis

VERMONT’S GARDENING EXPERIMENT

Researchers Name GB Sciences in Top 10

GB Sciences Files New Provisional Patent

GB Sciences Files New Patents

Radio Interview: John Poss on Bill Martinez Live

Watch this short video of GBLX CEO John Poss as he fields questions from the web

U.S. Senate links DOJ funding with medical marijuana protections

Cannabis as Antidepressant? Thinking Outside the Box

THE GOLDEN STATE IS GREEN: The ABC’s of Cannabis in California

420 Magazine: Louisiana’s Medical Marijuana Industry

MJ Biz Daily: Bipartisan Pitch to Resolve Cannabis Issues

Rolling Stone: Pot For All

TOO MUCH OF “A GOOD THING”?

Going Low and Slow: Dosing and Cannabis

Solving The Big Green Riddle…

GB Sciences to Serve Wider Louisiana Patient Base

Video: CEO John Poss discusses Rec, Science, and Tissue Culture

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Video: CEO John Poss talks European Trials

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Video: CEO John Poss talks Rec vs. Science

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Video: CEO John Poss talks CBD, Cura, Hemp

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Cannabis: the Early Years and What They Teach Us

MISSOURI

MIS

COLORADO

CNN: Patients turn to pot over pills

Video: What is a Cannabinoid?

The State of Alaska: Boom or Bust?

GB Seeks Minor Cannabinoids for Patient Studies

Louisiana House backs expansion of medical cannabis program

Video: CEO John Poss on a “Small but Complex” Company

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Video: CEO John Poss on Jeff Sessions

Watch this short video of GBLX CEO John Poss as he fields questions from the web

Cannabis and Dementia

New VP and General Counsel

STATE OF THE STATE: Washington State Marijuana Policy

GB Sciences and Parkinson’s Disease

Cannabis Nurse Video Blog

MAINE: The State Of Gifting

Cannabinoid-based, Time-Released Neuropathic Pain Formula

STATE OF THE STATE: New Jersey How Green Is the Garden State?

News: House Passes Budget with Medical Cannabis Protection Amendment

Ad Nauseam: How Cannabis Helps the Sickest Sick

Innovation in Medical Cannabis Therapies Symposium

Raphael Mechoulam — Cannabis Scientist

GB Sciences Partners with Colorado Hemp Project

On the Front: A Soldier’s Experience With PTSD

GB Sciences Receives Cannabis Oil Production License

YouTube: Spinach Veins Replace Human Blood Vessels

CEO John Poss Interview

GB Sciences Partners with Wellcana Group in Louisiana

The Amazing Endocannabinoid System

Medical Cannabis: A New York State of Mind

HuffPo: San Francisco Prosecutors to Overturn Cannabis Convictions

Nonprovisional Patent Application for Cannabis-Based Therapies

The New Yorker: Cannabis Wellness Industry in California

What the Heck Is a Cannabinoid?

News from Washington D.C.

Scientific Advisory Board Expands

The Potential of Medical Cannabis: Alzheimer’s Disease

The Diary of a Budding Cannabis Nurse

Maximizing Medical Benefit of Strains

Dr. Small-Howard invited to Neuroscience Forum

Guest Blogger: Becoming a Cannabis Nurse

GB Sciences: Research is in our Corporate DNA

Tissue Culture Propagation Breakthrough

GB Sciences is “Happy”

GBScience Forms Science Advisory Board

How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference

Cura Cannabis Solutions Oil Partnership

400% Sales Increase

How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference

Research Collaboration in Spain

How did they balance being so funny and being such respected artists?” This question was recently posed by a visitor in reference

LSU AgCenter Therapeutic Cannabis Program

GB Sciences Partners with Los Coyotes Band in California

GB Sciences Partners with Kush Cups Nevada